Why Is Pregabalin So Hard to Find? [Explained for 2026]

If you've recently walked out of a pharmacy empty-handed after trying to fill a pregabalin prescription, you're not imagining things. Despite pregabalin (brand name Lyrica) being one of the most commonly prescribed medications in the United States, patients frequently run into stock issues at individual pharmacies. So what's really going on — and is there an actual shortage?

The short answer: as of 2026, there is no active FDA-declared national shortage of pregabalin. Generics became available in 2019, and multiple manufacturers now produce the drug. But that doesn't mean every pharmacy near you has it in stock at every moment. Here's a detailed look at why availability can vary — and what patients can do about it.

Is Pregabalin in a Shortage in 2026?

Pregabalin is not on the FDA's current drug shortage list as of early 2026. Since generic pregabalin entered the market in 2019, numerous manufacturers have been producing the medication, which has significantly improved supply compared to the brand-name-only era. The availability of generics also brought the price down dramatically — from over $300 per month at retail to as low as $14 with a discount coupon like GoodRx.

However, "not in a national shortage" and "always in stock at your local CVS" are two very different things. Many patients still encounter pharmacies that are temporarily out of stock, particularly for specific strengths or formulations.

Why Do Some Pharmacies Run Out of Pregabalin?

Even when a drug isn't in a national shortage, individual pharmacies can run out temporarily. Several factors drive this:

• High and growing demand. Pregabalin is used for a wide range of conditions — diabetic neuropathy, postherpetic neuralgia, fibromyalgia, spinal cord injury pain, and partial-onset seizures. That means neurologists, pain specialists, psychiatrists, PCPs, and many other prescribers all write pregabalin scripts. High volume means pharmacies cycle through inventory quickly.
• Controlled substance status adds complexity. Pregabalin is a DEA Schedule V controlled substance. Pharmacies must comply with additional ordering, tracking, and dispensing regulations for controlled substances. This can slow restocking compared to non-scheduled drugs.
• Generic manufacturer variability. Different pharmacies source their generic pregabalin from different manufacturers. If one manufacturer has a supply hiccup or quality issue, pharmacies relying on that supplier may temporarily run short.
• Strength-specific gaps. Pregabalin comes in eight capsule strengths (25 mg through 300 mg) plus an oral solution and extended-release tablets. A pharmacy might have 75 mg capsules but be temporarily out of 150 mg or 300 mg.
• Smaller pharmacies with leaner inventories. Independent pharmacies and smaller chain locations may carry smaller quantities of any given medication, making stock-outs more likely when demand spikes.

Why Is Pregabalin a Controlled Substance — and Does That Affect Finding It?

Pregabalin's Schedule V status is worth understanding because it does affect how pharmacies manage the drug. The DEA placed pregabalin in Schedule V when it was first approved because clinical trials showed that a meaningful percentage of users (about 4%) experienced euphoria, and its dependence profile resembled mild sedatives. Schedule V is the lowest tier of federal drug scheduling — lower than opioids (Schedule II) or benzodiazepines (Schedule IV) — but it still comes with:

• State prescription monitoring program (PDMP) tracking requirements
• Regulated pharmacy ordering and DEA reporting requirements
• Limits on quantities some pharmacies stock based on usage patterns

These rules don't cause large-scale shortages, but they do mean that pharmacies are more measured in how much controlled-substance inventory they keep on hand. If they run out, restocking can take a few days longer than for a non-scheduled drug.

Does the Brand vs. Generic Distinction Matter for Availability?

Brand-name Lyrica and Lyrica CR (the extended-release formulation) are still manufactured by Viatris, but they are extremely expensive without insurance — often over $1,500 per month. The vast majority of prescriptions filled in the US in 2026 are for generic pregabalin, which is produced by multiple manufacturers. This wide manufacturing base is actually a key reason pregabalin is not in a shortage: if one supplier is short, there are alternatives.

That said, some pharmacies may stock only one or two generic manufacturers. If your pharmacy's preferred supplier is backordered, they may not automatically check alternative manufacturers without prompting. Asking the pharmacist specifically whether a different generic manufacturer has the drug in stock can sometimes resolve the issue on the spot.

Which Pregabalin Strengths Are Most Affected by Stock Issues?

In general, the most commonly prescribed strengths (75 mg and 150 mg capsules) tend to be the easiest to find because pharmacies stock them in higher quantities. Less commonly prescribed strengths — such as 25 mg, 200 mg, 225 mg, or the oral solution — may be harder to locate at smaller pharmacies. The extended-release Lyrica CR is primarily available at pharmacies with strong brand-name formulary stock.

What Should You Do If Your Pharmacy Doesn't Have Pregabalin?

Don't assume a stock-out means it's unavailable everywhere. Here are the most effective steps:

1. Call other pharmacies in your area. Availability varies by location. A different chain pharmacy or an independent pharmacy nearby may have your dose in stock.
2. Ask about a partial fill. Many pharmacies will dispense a partial supply (e.g., a 7-day supply) while waiting for the full order to arrive.
3. Use medfinder.
4. medfinder calls pharmacies near you to check who has your medication in stock, so you don't have to spend hours on hold. This is especially helpful when multiple strengths or formulations need to be checked.
5. Ask your prescriber about a dose equivalent. If 150 mg capsules are unavailable, your doctor might be able to write for two 75 mg capsules twice daily to achieve the same total daily dose. Always consult your provider before making any changes.
6. Consider mail-order pharmacy. Many insurance plans offer mail-order pharmacy services, which typically carry higher stock volumes. A 90-day supply via mail order can also save money.

What About Lyrica CR (Extended-Release) Availability?

Lyrica CR (pregabalin extended-release) is approved only for diabetic neuropathy pain and postherpetic neuralgia — not for fibromyalgia or seizures. Generic extended-release pregabalin is available, but the ER formulation is less widely stocked than regular capsules simply because fewer patients use it. If your pharmacy doesn't carry it, ask them to order it, or look for a pharmacy that specializes in specialty or chronic-care medications.

The Bottom Line: Pregabalin Availability in 2026

Pregabalin is not in a formal national shortage in 2026. Multiple generic manufacturers produce it, and it is widely available across the US. However, temporary, pharmacy-level stock-outs do happen — especially for less common strengths or in areas with high demand. The good news is that with the right strategy, you can almost always find your prescription filled nearby.

For step-by-step instructions on locating pregabalin in stock near you, see our guide: How to Find Pregabalin in Stock Near You. And if calling around feels overwhelming, medfinder does the calling for you.